X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (41) 41
mice (41) 41
humans (38) 38
article (32) 32
index medicus (29) 29
radioimmunotherapy (23) 23
cell line, tumor (22) 22
female (20) 20
trastuzumab (19) 19
tissue distribution (18) 18
chemistry (16) 16
cancer (15) 15
mice, nude (14) 14
peptides (14) 14
chemistry, organic (13) 13
oncology (13) 13
radioimmunotherapy - methods (13) 13
tumors (13) 13
immunotherapy (12) 12
ligands (12) 12
antibodies, monoclonal, humanized (11) 11
heterocyclic compounds (11) 11
human necessities (11) 11
hygiene (11) 11
medical or veterinary science (11) 11
metallurgy (11) 11
organic chemistry (11) 11
preparations for medical, dental, or toilet purposes (11) 11
acyclic or carbocyclic compounds (10) 10
biochemistry & molecular biology (10) 10
male (10) 10
positron-emission tomography (10) 10
xenograft model antitumor assays (10) 10
biochemical research methods (9) 9
chemistry, multidisciplinary (9) 9
monoclonal-antibody (9) 9
adhesives (8) 8
antibodies, monoclonal - chemistry (8) 8
antibodies, monoclonal - pharmacokinetics (8) 8
chelating agents - chemical synthesis (8) 8
compositions based thereon (8) 8
derivatives thereof (8) 8
disseminated peritoneal disease (8) 8
dna damage (8) 8
dyes (8) 8
lakes (8) 8
miscellaneous applications of materials (8) 8
miscellaneous compositions (8) 8
monoclonal antibodies (8) 8
mordants (8) 8
natural resins (8) 8
organic dyes or closely-related compounds for producing dyes (8) 8
organic macromolecular compounds (8) 8
paints (8) 8
pet (8) 8
pet imaging (8) 8
polishes (8) 8
polysaccharides (8) 8
radiation (8) 8
their preparation or chemical working-up (8) 8
apoptosis (7) 7
chelating agents - chemistry (7) 7
her1 (7) 7
in-vivo (7) 7
isothiocyanates - chemistry (7) 7
pentetic acid - analogs & derivatives (7) 7
research (7) 7
skin and connective tissue diseases (7) 7
biochemistry (6) 6
cancer therapies (6) 6
cetuximab (6) 6
chemistry, medicinal (6) 6
chromatography, high pressure liquid (6) 6
colonic neoplasms - pathology (6) 6
isotope labeling (6) 6
monoclonal antibody (6) 6
neoplasms (6) 6
ovarian-cancer (6) 6
pb-212 (6) 6
pentetic acid - chemistry (6) 6
proteins (6) 6
radiology, nuclear medicine & medical imaging (6) 6
radionuclide imaging (6) 6
spectrophotometric method (6) 6
therapy (6) 6
xenografts (6) 6
alpha particles - therapeutic use (5) 5
antineoplastic agents - pharmacology (5) 5
biodistribution (5) 5
cell cycle (5) 5
colonic neoplasms - genetics (5) 5
colonic neoplasms - radiotherapy (5) 5
dna (5) 5
dna repair (5) 5
gene expression (5) 5
glycine - analogs & derivatives (5) 5
growth-factor receptor (5) 5
her2 (5) 5
kinetics (5) 5
molecular structure (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Molecular Sciences, ISSN 1422-0067, 05/2016, Volume 17, Issue 5, pp. 736 - 736
Radiolabeled antibodies (mAbs) provide efficient tools for cancer therapy. The combination of low energy beta super(-)-emissions (500 keV sub(max); 130 keV... 
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2013, Volume 19, Issue 3, pp. 530 - 537
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 1601 - 1601
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2011, Volume 128, Issue 4, pp. 920 - 926
Bevacizumab is a humanized monoclonal antibody that binds to tumor‐secreted vascular endothelial growth factor (VEGF)‐A and inhibits tumor angiogenesis. In... 
bevacizumab | 86Y | PET imaging | VEGF‐A | angiogenesis | VEGF-A | Angiogenesis | Bevacizumab
Journal Article
International Journal of Radiation Oncology, Biology and Physics, ISSN 0360-3016, 03/2013, Volume 85, Issue 4
Purpose: To elucidate the mechanism of the therapeutic efficacy of targeted α-particle radiation therapy using {sup 212}Pb-TCMC-trastuzumab together with... 
APOPTOSIS | LARGE INTESTINE | CHROMATIN | NEOPLASMS | PHOSPHORYLATION | RADIOIMMUNOTHERAPY | COMPARATIVE EVALUATIONS | 60 APPLIED LIFE SCIENCES | STRAND BREAKS | LEAD 212 | DNA | BIOLOGICAL REPAIR | CELL KILLING | RADIOLOGY AND NUCLEAR MEDICINE | CELL CYCLE | MICE | PROTEINS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 03/2013, Volume 85, Issue 4, pp. 1119 - 1126
Purpose: To elucidate the mechanism of the therapeutic efficacy of targeted [alpha]-particle radiation therapy using 212Pb-TCMC-trastuzumab together with... 
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 03/2013, Volume 85, Issue 4, p. 1119
To elucidate the mechanism of the therapeutic efficacy of targeted [alpha]-particle radiation therapy using.sup.212Pb-TCMC-trastuzumab together with... 
Gemcitabine | Nuclear radiation | DNA damage | Immunotherapy | DNA | Radiotherapy | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0159904
Journal Article
Bioorganic and Medicinal Chemistry Letters, ISSN 0960-894X, 09/2012, Volume 22, Issue 17, pp. 5517 - 5522
There is growing interest in small peptidomimetic [alpha]v[beta]3 integrin antagonists that are readily synthesized and characterized and can be easily handled... 
Angiogenesis | Computed tomography | Radioimmunoassay | Radioisotopes | Antagonists | peptidomimetics | Chelates | Single photon emission computed tomography | Integrins | Tumors
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 09/2012, Volume 22, Issue 17, p. 5517
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 4, pp. 1119 - 1126
Purpose To elucidate the mechanism of the therapeutic efficacy of targeted α-particle radiation therapy using212 Pb-TCMC-trastuzumab together with gemcitabine... 
Radiology | Hematology, Oncology and Palliative Medicine
Journal Article
ISSN 1477-9226, 10/2017, Volume 46, Issue 42, pp. 14591 - 1461
Identification of the appropriate combination of radionuclide, target and targeting vehicle is critical for successful radioimmunotherapy. For the treatment of... 
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2011, Volume 6, Issue 3, p. e18198
Malignant mesothelioma (MM), a rare form of cancer is often associated with previous exposure to fibrous minerals, such as asbestos. Asbestos exposure... 
Viral antibodies | Antimitotic agents | Occupational health and safety | Asbestos | PET imaging | Immunotherapy | Antibodies | Mesothelioma | Radiotherapy | Antineoplastic agents | Cancer
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 05/2016, Volume 17, Issue 5, p. 736
Radiolabeled antibodies (mAbs) provide efficient tools for cancer therapy. The combination of low energy β−-emissions (500 keVmax; 130 keVave) along with a... 
Lu-Radioimmunotherapy (RIT) | Micrometastatic disease | DNA double strand breaks | DNA repair | Apoptosis | micrometastatic disease | apoptosis | 177Lu-Radioimmunotherapy (RIT)
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 03/2013, Volume 85, Issue 4, pp. 1119 - 1126
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.